An update review on recent skin fillers

Abstract

Facial rejuvenation has changed over the last decade, evolving from the rhytidectomy to an approach that focuses on revolumization, due to a more complete understanding of the changes to bone and soft tissue that occur with the aging face. Soft tissue augmentation using various injectable filler agents has gained popularity due to their nonsurgical, non-invasive procedures, instant cosmetic outcomes and limited recovery time. The skin filler market is booming and the variety of available skin fillers is increasing, providing the plastic surgeons many choices. Nonpermenant, biodegradable, resorbable agents may induce little complications, but they will normally disappear soon after injection. Semipermenant, biodegradable, biostimulary, nonresorbable fillers may induce a bit more complications, but they will normally disappear spontaneously in a few months. Permanent, nonresorbable fillers usually give rise to severe complications or reactions which may not disappear spontaneous. They may appear several years after the injection, and treatment is often insufficient. Unfortunately, the ideal filler with lasting effect but without any complication has not been discovered yet. In this review, we give an update on currently available skin filler agents, and what is new in recent 5 years.

Keywords

Skin fillers / revolumization / biodegradable / biostimulory / nonresorbable / bovine collagen / hyaluronic acid / polyacrylamide

References

[1] Pak CS,Lee H,Kim EH,Choi H,Oh S,Heo CY.A phase III, randomized, double-blind, matched-pairs, active-controlled clinical trial and preclinical animal study to compare the durability, efficacy and safety between polynucleotide filler and hyaluronic acid filler in the correction of crow's feet: a new concept of regenerative filler..J Korean Med Sci2014;29 Suppl 3:S201-9 PMCID:PMC4248006

[2] 2014 Complete Plastic Surgery Statistic Report. Ameircan Society of Plastic Surgeons. Available from: http://www.plasticsurgery.org/news/plastic-surgery-statistics/2014-plastic-surgery-statistics.html

[3] Carruthers J,Humphrey S.Introduction to fillers..Plast Reconstr Surg2015;136 Suppl 5:S120-31

[4] Requena L,Christensen L,Kutzner H.Adverse reactions to injectable soft tissue fillers..J Am Acad Dermatol2011;64:1-34

[5] Christensen L,Janssen M,Hogdall E.Adverse reactions to injectable soft tissue permanent fillers..Aesthetic Plast Surg2005;29:34-48

[6] De Boulle K.Management of complications after implantation of fillers..J Cosmet Dermatol2004;3:2-15

[7] Bertossi D,Cerini R,Favero V,Ruzzenente O,Guidi GC.Hyaluronic acid: in vitro and in vivo analysis, biochemical properties and histological and morphological evaluation of injected filler..Eur J Dermatol2013;23:449-55

[8] Wang F,Kang S,Orringer JS,Voorhees JJ.In vivo stimulation of a de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin..Arch Dermatol2007;143:155-63

[9] Turlier V,Casas C,Bianchi P,Josse G,Dahan S,Theunis J,Degouy A,Redoulès D.Association between collagen production and mechanical stretching in dermal extracellular matrix: in vivo effect of cross-linked hyaluronic acid filler. A randomised, placebo-controlled study..J Dermatol Sci2013;69:187-94

[10] Watson W,Klein A.Collagen: a clinical overview..Cutis1983;31:543-6

[11] Klein AW.Dermatology: bovine injectable collagen..West J Med1985;143:231 PMCID:PMC1306281

[12] Knapp TR,Daniels JR.Injectable collagen for soft tissue augmentation..Plast Reconstr Surg1977;60:389-405

[13] Stegman SJ,Bensch K.A light and electron microscopic evaluation of Zyderm collagen and Zyplast implants in aging human facial skin: a pilot study..Arch Dermatol1987;123:1644-9

[14] Douglas RS,Cook T.Collagen fillers in facial aesthetic surgery..Facial Plast Surg2004;20:117-23

[15] Mullins RJ,Walker T.Allergic reaction to oral, surgical and topical bovine collagen. Anaphylactic risk for surgeons..Aust N Z J Ophthalmol1996;24:257-60

[16] Siegle RJ,Schade W.Intradermal implantation of bovine collagen. humoral immune responses associated with clinical reactions..Arch Dermatol1984;120:183-7

[17] Sclafani A,Jacono AA,Cocker R.Evaluation of acellular dermal graft in sheet (Alloderm) and injectable (micronized Alloderm) forms for soft tissue augmentation: clinical observations and histologic findings..Arch Facial Plast Surg2000;2:130-6

[18] Fagien S.Facial soft-tissue augmentation with injectable autologous and allogenic human tissue collagen matrix (autologen and dermalogen)..Plast Reconstr Surg2000;105:362-73

[19] Moody BR.Self-limited adverse reaction to human-derived collagen injectable product..Dermatol Surg2000;26:936-8

[20] Wise JB.Injectable treatments for the aging face..Facial Plast Surg2006;22:140-6

[21] Lupo MP.Hyaluronic acid fillers in facial rejuvenation..Semin Cutan Med Surg2006;25:122-6

[22] Termeer C,Sleeman J,Voith U,Miyake K,Galanos C.Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4..J Exp Med2002;195:99-111 PMCID:PMC2196009

[23] Mansouri Y.Update on hyaluronic acid fillers for facial rejuvenation..Cutis2015;96:85-8

[24] Turlier V,Casas C,Bianchi P,Josse G,Dahan S,Theunis J,Degouy A,Redoulès D.Association between collagen production and mechanical stretching in dermal extracellular matrix: in vivo effect of cross-linked hyaluronic acid filler. A randomised, placebo-controlled study..J Dermatol Sci2013;69:187-94

[25] Quan T,Shao Y,Xia W,Voorhees JJ.Enhancing structural support of the dermal microenvironment activates fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo..J Invest Dermatol2013;133:658-67 PMCID:PMC3566280

[26] Duranti F,Bovani B,Rosati ML.Injectable hyaluronic acid gel for soft tissue augmentation. A clinical and histological study..Dermatol Surg1998;24:1317-25

[27] Narins RS,Leyden J,Rubin M.A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds..Dermatol Surg2003;29:588-95

[28] Palm MD.Filler frontier: what's new and heading West to the US market..Semin Cutan Med Surg2014;33:157-63

[29] Brandt FS.Hyaluronic acid gel fillers in the management of facial aging..Clin Interv Aging2008;3:153-9

[30] Mansouri Y.Update on hyaluronic acid fillers for facial rejuvenation..Cuti2015;96:85-8

[31] Pollack SV.Some new injectable dermal filler materials: Hylaform, Restylane and Artecoll..J Cutan Med Surg1999;Suppl 4:S27-35

[32] Rongioletti F,Sottofattori E.Granulomatous reaction after intradermal injections of hyaluronic acid gel..Arch Dermatol2003;139:815-6

[33] Shafir R,Gur E.Long-term complications of facial injections with Restylane (injectable hyaluronic acid)..Plast Reconstr Surg2000;106:1215-6

[34] Dal Sacco D,Parody A.Scar sarcoidosis after hyaluronic acid injection..Int J Dermatol2005;44:411-2

[35] Descamps V,Frances C,Ratziu V.Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases..Dermatol2008;217:81-4

[36] Schanz S,Ulmer A,Fierlbeck G.Arterial embolization caused by injection of hyaluronic acid (Restylane)..Br J Dermatol2002;146:928-9

[37] Grossman KL.Hyaluronic acid gel fillers: hypersensitivity reactions..Aesthet Surg J2005;25:403-5

[38] Leonard JM,Narin RS.Angioedema acute hypersensitivity reaction to injectable hyaluronic acid..Dermatol Surg2005;31:577-9

[39] Schierle CF.Nonsurgical rejuvenation of the aging face with injectable poly-L-lactic acid for storation of soft tissue volume..Aesthet Surg J2011;31:95-109

[40] Ladewig K,Andrea J O'Connor.Designing in vivo bioreactors for soft tissue engineering..J Biomater Tissue Engineering2012;2:1-13

[41] Gogolewski S,Perren SM,Hughes MK.Tissue response and in vivo degradation of selected poly-hydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB) and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA)..J Biomed Mater Res1993;27:1135-48

[42] Lam SM,Graivier M.Injectable poly-L-lactic acid (Sculptra): technical considerations in soft-tissue contouring..Plast Reconstr Surg2006;118:S55-63

[43] Vleggaar D.Facial volumetric correction with injectable poly-L-lactic acid..Dermatol Surg2005;31:1511-7

[44] Vleggaar D.Facial enhancement and the European experience with Sculptra (poly-L-lactic acid)..J Drugs Dermatol2004;3:542-7

[45] Athanasiou KA,Agrawal CM.Applications of biodegradable lactides and glycolides in podiatry..Clin Podiatr Med Surg1995;12:475-95

[46] Spenlehauer G,Benoit JP.In vitro and in vivo degradation of poly(D, L-lactide/glycolide) acid microspheres made by solvent evaporation method..Biomater1989;10:557-63

[47] Vleggaar D.Soft-tissue augmentation and the role of poly-L-lactic acid..Plast Reconstr Surg2006;118:S46-54

[48] Valantin MA,Ghosn J,Pauchard M,Bousquet R,Costagliola D.Polylactic acid implants (New-Fill) to correct facial lipoatrophy in HIV-infected patients: results of the open-label study..AIDS2003;17:2471-7

[49] Lemperle G,Gauthier-Hazan N.Avoiding and treating dermal filler complications..Plast Reconstr Surg2006;118:S92-107

[50] Alijotas-Reig J,Puig L.Inflammatory, immune-mediated adverse reactions related to soft tissue dermal fillers..Semin Arthritis Rheum2013;43:241-58

[51] Fan M,Guo G,Yang Y,Qian Z.Dexamethasone-loaded poly (D,L-lactic acid) microspheres/poly (ethylene glycol) = poly (epsilon-caprolactone) – poly (ethylene glycol) micelles composite for skin augmentation..J Biomed Nanotechnol2014;10:592-602

[52] Lafaurie M,Porcher R,Madelaine I.Treatment of facial lipoatrophy with intradermal injections of polylactic acid in HIV-infected patients..J Acquir Immune Defic Syndr2005;38:393-8

[53] Tzikas TL.Evaluation of the radiance FN soft tissue filler for facial soft tissue augmentation..Arch Facial Plast Surg2004;6:234-9

[54] Marmur ES,Goldberg DJ.Clinical, histologic and electron microscopic findings after injection of a calcium hydroxylapatite filler..J Cosmet Laser Ther2004;6:223-6

[55] Broder KW.An overview of permanent and semipermanent fillers..Plast Reconstr Surg2006;118:7S-14S

[56] Silvers SL,Echavez MI.Prospective, open-label, 18-month trial of calcium hydroxylapatite (Rad-iesse) for facial soft-tissue augmentation in patient with human immunodeficiency virus-associated lipoatrophy: one-year durability..Plast Reconstr Surg2006;118:S34-45

[57] Sklar JA.Radiance FN: a new soft tissue filler..Dermatol Surg2004;30:764-8

[58] Jansen DA.Evaluation of calcium hydroxylapatite based implant (Radiesse) for facial soft-tissue augmentation..Plast Reconstr Surg2006;118:S22-30

[59] Ahn MS.Calcium hydroxylapatite: Radiesse..Facial Plast Surg Clin North Am2007;15:85-90

[60] Duffy DM.Complications of fillers. Overview..Dermatol Surg2005;31:1626-33

[61] Beer KR.Radiesse nodule of the lips from a distant injection site: report of a case and consideration of etiology and management..J Drugs Dermatol2007;6:846-7

[62] Kim JA.Neocollagenesis in human tissue injected with a polycaprolactone-based dermal filler..J Cosmet Laser Ther2015;17:99-101

[63] Moers-Carpi MM.Polycaprolactone for the correction of nasolabial folds: a 24-month, rospective, randomized, controlled clinical trial..Dermatol Surg2013;39:457-63 PMCID:PMC3615178

[64] Figueiredo VM.A five-patient prospective pilot study of a polycaprolactone based dermal filler for hand rejuvenation..J Cosmet Dermatol2013;12:73-7

[65] Nicolau PJ.Neocollagenesis after injection of a polycaprolactone based derma filler in a rabbit..Eur J Aesth Med Dermatol2013;3:19-26

[66] Leonardis M.New-generation filler based on cross-linked carboxymethylcellulose: study of 350 patients with 3-year follow-up..Clin Interv Aging2015;10:147-55 PMCID:PMC4293293

[67] Leonardis M,Dornelles RF.Use of cross-linked carboxymethyl cellulose for soft-tissue augmentation: preliminary clinical studies..Clin Interv Aging2010;5:317-22 PMCID:PMC3010166

[68] Neuber F.Fettransplantation..Chir Kongr Verhandl Dsch Gesellch Chir1893;22:66

[69] Cervelli V,Pascali M,Curcio BC.Autologous platelet-rich plasma mixed with purified fat graft in aesthetic plastic surgery..Aesthetic Plast Surg2009;33:716-21

[70] Sterodimas A,Nicaretta B,Papalambros E.Cell-assisted lipotransfer..Aesthet Surg J2010;30:78-81

[71] Ersek RA.Transplantation of purified autologous fat: a 3-year follow-up is disappointing..Plast Reconstr Surg1991;87:219-27

[72] Coleman SR.Long-term survival of fat transplants: controlled demonstrations..Aesthetic Plast Surg1995;19:421-5

[73] Fulton JE,Silverton K.Small volume fat transfer..Dermatol Surg1998;24:857-65

[74] Fournier PF.Fat grafting: my technique..Dermatol Surg2000;26:1117-28

[75] Kanchwala SK.Facial fat grafting: the search for predictable results..Facial Plast Surg2003;19:137-46

[76] Cheng JT,Hamilton MM.Collagen and injectable fillers..Otolaryngol Clin North Am2002;35:73-85

[77] Carruthers JD,Rohrich RJ,Carruthers A.Blindness caused by cosmetic filler injection: a review of cause and therapy..Plast Reconstr Surg2014;134:1197-201

[78] Hong DK,Lee JH.Sudden visual loss and multiple cerebral infarction after autologous fat injection into the glabella..Dermatol Surg2014;40:485-7

[79] Yamauchi PS.Emerging permanent filler technologies: focus on aquamid..Clin Cosmet Investig Dermatol2014;7:261-6 PMCID:PMC4199851

[80] Peters W.Complications from injectable materials used for breast augmentation..Can J Plast Surg2009;17:89-96

[81] Altmeyer MD,Wang AR.Silicone migration and granuloma formation..J Cosmet Dermatol2009;8:92-7

[82] Schwartzfarb EM,Romanelli P.Foreig body granuloma formation secondary to silicone injection..Dermatol Online J2008;14:20

[83] Ficarra G,Carlos R.Silicone granuloma of the facial tissues: a report of seven cases..Oral Surg Oral Med Oral Pathol Oral Radiol Endod2002;94:65-73

[84] Schmid A,Leshko L.Silicone embolism syndrome: a case report, review of the literature, and comparison with fat embolism syndrome..Chest2005;127:2276-81

[85] Vent J.Prevention and treatment of complications after polymethylmethacrylate-microspheres injections..Facial Plast Surg2014;30:628-34

[86] Lemperle G,Fortes FB.Can injection of PMMA-microspheres cause hypercalcemia?.Clin Cases Miner Bone Metab2015;12:82-3

[87] Bachmann F,Hartmann V,Wiest L.Adverse reactions caused by consecutive injections of different fillers in the same facial region: risk assessment based on the results from the injectable filler safety study..J Eur Acad Dermatol Venereol2011;25:902-12

[88] Limongi RM,Borba A,Pimentel AR,Velasco E Cruz AA.Complications and management of polymethylmethacrylate (PMMA) injections to the midface..Aesthet Surg J2016;36:132-5

[89] Christensen LH,Aasted A,Kebuladze I.Long-term effects of polyacrylamide hydrogel on human breast tissue..Plast Reconstr Surg2003;111:1883-90

[90] Breiting V,Jørgensen A,Rosetzsky A.A study on patients treated with polyacrylamide hydrogel injection for facial corrections..Aesthetic Plast Surg2004;28:45-53

[91] Von Buelow S,Pallua N.Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation..Plast Reconstr Surg2005;116:1137-46

[92] Von Buelow S.Efficacy and safety of polyacrylamide hydrogel for facial soft-tissue augmentation in a 2-year follow-up: a prospective multicenter study for evaluation of safety and aesthetic results in 101 patients..Plast Reconstr Surg2006;118:S85-91

[93] De Santis G,Baccarani A,Pinelli M,Guaraldi G.Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: a 2-year clinical experience..Plast Reconstr Surg2008;121:644-53

[94] Negredo E,Aldea D,Estany C,Rodríguez-Fumaz C,Higueras C,Clotet B.Four-year safety with polyacrylamide hydrogel to correct antiretroviral-related facial lipoatrophy..AIDS Res Hum Retroviruses2009;25:451-5

[95] Wolters M.Prospective multicenter study for evaluation of safety, efficacy, and esthetic results of crosslinked polyacrylamide hydrogel in 81 patients..Dermatol Surg2009;35 Suppl 1:338-43

[96] Mole B,Carbonnel E,Brazille P,Mercier S,Weiss L.Polyacrylamide hydrogel injection in the management of human immunodeficiency virus-related facial lipoatrophy: results of the LIPOPHILL open-label study..AIDS Res Hum Retroviruses2012;28:251-8

[97] Lafaurie M,Girard PM,Bouchaud O,Madelaine I,Porcher R.Polylactic acid vs. polyacrylamide hydrogel for treatment of facial lipoatrophy: a randomized controlled trial [Agence Nationale de Recherches sur le SIDA et les Hépatites Virales (ANRS) 132 SMILE]..HIV Med2013;14:410-20

[98] Narins RS,Rohrich R,Glogau R,Bruce S,Dayan S,Maas C,Sclafani A.12-Month controlled study in the United States of the safety and efficacy of a permanent 2.5% polyacrylamide hydrogel softtissue filler..Dermatol Surg2010;36 Suppl 3:1819-29

[99] Fernández-Cossío S.Biocompatibility of two novel dermal fillers: histological evaluation of implants of a hyaluronic acid filler and a polyacrylamide filler..Plast Reconstr Surg2006;117:1789-96

[100] Christensen L,Bjarnsholt T,Høgdall E,Pallua N.Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery..Clin Infect Dis2013;56:1438-44

[101] Nygart JF,Borggren M.Effect of prophylactic antibiotics on polyacrylamide gel safety in facial augmentation..J Drugs Dermatol2014;13:571-3

[102] Ersek RA.Bioplastique: a new texture copolymer microparticle promises permanence in soft tissue augmentation..Plast Reconstr Surg1991;33:693-702

[103] Rudolph CM,Schuller-Petrovic S.Bioplastiquegranulom..Hautarzt1997;48:749-52

[104] Hoffmann C,Soyer HP.Adverse reactions after cosmetic augmentation with permanent biologically inert implant materials..J Am Acad Dermatol1999;40:100-2

[105] Rudolph CM,Schuller-Petrovic S.Foreign body granulomas due to injectable aesthetic microimplants..Am J Surg Pathol1999;23:113-7

[106] Margolis DM.Treatment for lipoatrophy: facing the real costs..AIDS2007;21:1819-20

[107] Nelson L.Experience in the treatment of HIV-associated lipodystrophy..J Plast Reconstr Aesthet Surg2008;61:366-71

[108] Karim RB,Van Galen SR,Nieuwkerk PT,Hage JJ.Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients..Aesthetic Plast Surg2008;32:873-8

[109] Mallewa JE,Vilar J,Doran D,Pirmohamed M.HIV-associated lipodystrophy: a review of underlying mechanisms and therapeutic options..J Antimicrob Chemother2008;62:648-60

[110] Hönig J.Cheek augmentation with Bio-Alcamid in facial lipoatrophy in HIV seropositive patients..J Craniofac Surg2008;19:1085-8